- idUS
- Listar por autor
Listar por autor "Ruiz-Borrego, Manuel"
Mostrando ítems 1-2 de 2
-
Artículo
Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
Gasca, Jessica; Flores de Mera, María de la Luz; Giraldez Macias, Servando; Tortolero García, María Dolores; Ruiz-Borrego, Manuel; Romero Portillo, Francisco; Japón, Miguel A.; Sáez, Carmen (Impact Journals, 2016)FBXW7 is a component of SCF (complex of SKP1, CUL1 and F-box-protein)-type ubiquitin ligases that targets several oncoproteins ...
-
Artículo
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
Lluch, Ana; Barrios, Carlos H.; Torrecillas, Laura; Ruiz-Borrego, Manuel; Bines, José; Guerrero-Zotano, Ángel; Salvador Bofill, Francisco Javier; Martín, Miguel (American Society of Clinical Oncology, 2020)PURPOSE Operable triple-negative breast cancers (TNBCs) have a higher risk of relapse than non-TNBCs with standard ...